MoonLake Immunotherapeutics (MLTX) Cash from Operations Growth (1y) (2022 - 2026)
MoonLake Immunotherapeutics (MLTX) Cash from Operations Growth (1y) (2022 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,725.60 Bn | 68,725.31 Bn | - | 7.14% |
| 2 | Nanobiotix | 1,953.19 Bn | 1,953.13 Bn | - | - |
| 3 | Akari Therapeutics | 1,132.35 Bn | 1,132.35 Bn | - | - |
| 4 | BeOne Medicines | 472.73 Bn | 467.94 Bn | 1.35 Bn | 356.73% |
| 5 | Vertex Pharmaceuticals | 123.52 Bn | 116.27 Bn | 2.59 Bn | 74.39% |
| 6 | Regeneron Pharmaceuticals | 69.74 Bn | 60.99 Bn | 3.31 Bn | 3.23% |
| 7 | Belite Bio | 63.09 Bn | 63.09 Bn | - | - |
| 8 | Argenx Se | 56.42 Bn | 51.24 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.76 Bn | 37.76 Bn | - | - |
| 10 | MoonLake Immunotherapeutics | 1.41 Bn | 1.05 Bn | - | -73.80% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -73.80% |
| Dec 31, 2025 | -21.29% |
| Sep 30, 2025 | -76.23% |
| Jun 30, 2025 | -95.52% |
| Mar 31, 2025 | -155.15% |
| Dec 31, 2024 | -292.68% |
| Sep 30, 2024 | -173.24% |
| Jun 30, 2024 | -129.38% |
| Mar 31, 2024 | -65.64% |
| Dec 31, 2023 | -6.45% |
| Sep 30, 2023 | 1.08% |
| Jun 30, 2023 | 41.43% |
| Mar 31, 2023 | 36.38% |
| Dec 31, 2022 | 67.03% |
| Sep 30, 2022 | -363.27% |
| Jun 30, 2022 | 18.89% |
| Mar 31, 2022 | -13,060.13% |